Serial #79213073
LIVE

Serial Number

79213073

Owner

Telix Pharmaceuticals Pty Ltd

Filing Date

May 30, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79213073 Trademark

Serial Number: 79213073 • Registration: 5624611

Serial #79213073 is a trademark filed by Telix Pharmaceuticals Pty Ltd on May 30, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Pty Ltd (2 trademarks)

Suite 401,

Entity Type: 99

Trademark Details

Filing Date

May 30, 2017

Registration Date

December 11, 2018

Published for Opposition

September 25, 2018

Cancellation Date

June 27, 2025

Goods & Services

Apparatus for administering pharmaceuticals, namely, medical apparatus for introducing pharmaceutical preparations into the human body; apparatus for medical purposes, namely, injection needles and injection syringes, radiological apparatus for medical purposes; medical apparatus for the treatment of cancer; imaging apparatus for medical use for diagnosing medical conditions; drug delivery systems, namely, applicators for pharmaceutical preparations sold without medication; all of the aforementioned for use in the detection or treatment of cancer

Chemicals for pharmaceutical use in the nature of chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; pharmaceutical drugs and pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products, namely, radiopharmaceutical diagnostic preparations and radiopharmaceutical treatment preparations for treatment of cancer

Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer

Licensing of intellectual property

Advertising services; business advisory services relating to product development; business consultancy; retail or wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialisation of goods, namely, procuring of contracts for third parties for the purchase and sale of goods

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 27, 2026 INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 27, 2026 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
CANCELLED SECTION 71
Jun 27, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 11, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 5, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 19, 2019 FICS
FINAL DISPOSITION PROCESSED
Mar 19, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 11, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 11, 2018 R.PR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sep 27, 2018 CORN
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 25, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 25, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Sep 21, 2018 GPNX
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 20, 2018 CRCV
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 5, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 5, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 5, 2018 OP2R
ASSIGNED TO LIE
Aug 23, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2018 CNSA
ASSIGNED TO EXAMINER
Aug 9, 2018 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 27, 2018 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 26, 2018 ADCH
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 13, 2018 ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 13, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 19, 2018 GNFN
FINAL REFUSAL E-MAILED
May 19, 2018 GNFR
FINAL REFUSAL WRITTEN
May 19, 2018 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 27, 2018 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2018 TROA
REFUSAL PROCESSED BY IB
Sep 22, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 1, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 1, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 30, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 29, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 1, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 27, 2017 REPR